McKesson Corporation ($MCK) Stock Forecast: Down 1.2% Today

What is McKesson Corporation?

McKesson Corporation (NYSE: MCK) is a healthcare company specializing in pharmaceuticals and medical supplies. The market has been stable, with McKesson surpassing market performance over the past 15 years.

Why is McKesson Corporation going down?

MCK stock is down 1.2% on Jun 3, 2025 14:41

• The recent downtrend in McKesson's stock could be due to profit-taking by investors following an extended period of growth.
• Market movements may reflect wider economic uncertainties or specific challenges within the healthcare sector affecting the company's stock value.
• Investor decisions may be influenced by short-term market changes rather than the company's overall long-term success.
• Monitoring McKesson's response to the market decline and potential factors that could reverse this trend is important going forward.

MCK Price Chart

MCK Technical Analysis

MCK News

Here's How Much You Would Have Made Owning McKesson Stock In The Last 15 Years - McKesson ( NYSE:MCK )

McKesson MCK has outperformed the market over the past 15 years by 4.95% on an annualized basis producing an average annual return of 16.79%. Currently, McKesson has a market capitalization of $90.09 billion.

https://www.benzinga.com/insights/news/25/05/45634118/heres-how-much-you-would-have-made-owning-mckesson-stock-in-the-last-15-years

Trending Today

Bitcoin Cash ($BCH) Crypto Forecast: Up 5.2% Today

Bitcoin SV ($BSV) Crypto Forecast: Up 5.1% Today

Pepe ($PEPE) Crypto Forecast: Down 6.0% Today

Arbitrum ($ARB) Crypto Forecast: Up 5.7% Today

Cardano ($ADA) Crypto Forecast: Up 5.4% Today

Ethereum ($ETH) Crypto Forecast: Up 5.1% Today

XRP ($XRP) Crypto Forecast: Up 6.9% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Up 5.3% Today

Bumble Inc. ($BMBL) Stock Forecast: Up 5.2% Today

Advanced Micro Devices Inc. ($AMD) Stock Forecast: Up 6.3% Today

McKesson Corporation Price History

13.00.2025 - MCK Stock was up 1.3%

• The bullish movement in MCK likely stems from positive sentiment in the pharmaceutical sector, potentially fueled by robust earnings or promising drug advancements.
• This upward trend in MCK may also be buoyed by general market positivity, as evidenced by the strong performance of similar companies such as PDEX.
• Investors could be perceiving MCK as a secure investment option, resulting in heightened buying activity and an upward push in the stock price.

05.08.2024 - MCK Stock was down 8.3%

• The bearish movement in McKesson's stock today could be attributed to the recent $300 million opioid settlement that the company, along with other drug distributors, has agreed to pay to resolve claims from health insurers and benefit plans. This settlement could have negative financial implications for McKesson in the short term.
• Bearish options activity observed by investors on McKesson's stock further indicates a lack of confidence or pessimistic sentiment surrounding the company's future performance.
• The market may be reacting to the uncertainty and potential financial impact of the settlement on McKesson's profitability and reputation, leading to a sell-off of the stock by investors anticipating a downturn in the company's prospects.
• Overall, the combination of the negative news regarding the opioid settlement and the bearish options activity likely contributed to the significant bearish movement in McKesson's stock today.

03.05.2025 - MCK Stock was down 1.2%

• The recent downtrend in McKesson's stock could be due to profit-taking by investors following an extended period of growth.
• Market movements may reflect wider economic uncertainties or specific challenges within the healthcare sector affecting the company's stock value.
• Investor decisions may be influenced by short-term market changes rather than the company's overall long-term success.
• Monitoring McKesson's response to the market decline and potential factors that could reverse this trend is important going forward.

14.00.2025 - MCK Stock was up 0.6%

• McKesson exhibited significant bullish momentum today, surpassing market benchmarks.
• The company has consistently outperformed the market, delivering an average yearly return of 16.04% over the past 15 years.
• McKesson's robust position in the healthcare field and its adeptness in responding to market dynamics likely underlie its strong performance.
• Investor optimism regarding McKesson's future growth potential appears to be driving the bullish stock movement.

24.08.2024 - MCK Stock was down 6.5%

• McKesson's stock decreased by -0.68% today, going against the overall market direction.
• Despite increased options activity suggesting optimism among investors, the stock did not perform positively.
• Despite strong collaborations and Biologics strength, external market conditions could have impacted the stock's decline.
• Analyst downgrades and general market sentiment likely played a role in the stock's bearish movement.

15.09.2024 - MCK Stock was up 2.3%

• Over the past 5 years, McKesson (MCK) has delivered an impressive average annual return of 29.57%, surpassing market performance by a considerable margin.
• The closing price of McKesson (MCK) stood at $502.12, reflecting a +1.42% change compared to the previous trading session.
• The robust bullish trend in McKesson's stock today may be linked to its consistent market outperformance, signaling investor trust in the company's growth prospects and financial health.

07.10.2024 - MCK Stock was up 12.4%

• Recent positive developments contributed to McKesson's stock rise:
• Increased options activity indicated investor optimism about the company's future.
• Analysts raised their forecasts post a favorable earnings report, emphasizing the company's strong financial results.
• McKesson exceeded Q2 earnings and revenue expectations, further boosting investor confidence.
• The company's long-term market outperformance, demonstrated by a significant return on investment spanning two decades, attracted more investors, leading to a rise in stock value.

07.10.2024 - MCK Stock was up 9.4%

• McKesson reported better-than-expected second-quarter financial results, with earnings of $7.07 per share and sales of $93.70 billion, beating analyst estimates. This positive earnings report likely contributed to the bullish movement.
• Analysts have turned bullish on McKesson, with upgrades and increased price targets following the upbeat earnings report. This positive sentiment from analysts could have further boosted the stock.
• The company's consistent outperformance over the past 20 years, with an average annual return of 15.46%, has likely attracted investors looking for long-term growth opportunities.
• Expectations for solid performance in the U.S. Pharmaceutical and Specialty Solutions segment in the upcoming earnings report may have also fueled investor optimism and contributed to the bullish movement in the stock.

07.10.2024 - MCK Stock was up 11.0%

• Today, McKesson's strong bullish movement is supported by several factors:
• Increased options activity and positive investor sentiment suggest confidence in the company's future.
• Second-quarter fiscal 2025 results surpassing expectations, especially in the U.S. Pharmaceutical segment, have contributed to a favorable market outlook.
• Analysts revising their forecasts upward and expressing optimism about McKesson post-earnings have further encouraged investor confidence.
• In conclusion, robust earnings performance and a positive outlook for McKesson have driven the stock's bullish trend today.

09.04.2025 - MCK Stock was down 2.6%

• Today's downward movement in MCK may be linked to profit-taking by investors following strong year-to-date gains.
• Despite surpassing Q4 earnings estimates and seeing optimistic options activity, concerns about future growth could have led to a sell-off.
• Broker opinions, which include a Buy rating but also express doubts about the effectiveness of such recommendations, might have contributed to investor hesitancy.
• The positive outlook for Q4 earnings reflecting the performance of the U.S. Pharmaceutical and Specialty Solutions segment may not have been sufficient to counter broader market sentiment or profit-taking activities.

06.01.2025 - MCK Stock was down 5.2%

• Following the release of its Q3 earnings report, McKesson's stock faced a downturn due to missing expectations and a decrease in gross margin, particularly in the Medical Surgical Solutions segment.
• The acquisition of PRISM Vision Holdings was viewed positively as a move to bolster McKesson's specialty care capabilities and leadership in eye health solutions. However, this development did not have an immediate impact on the stock price.
• Despite anticipated strong performance in the U.S. Pharmaceutical and Specialty Solutions segment, McKesson's stock performed worse than the overall market, reflecting investor apprehensions.
• The market response to McKesson's Q3 earnings indicates that investors may have been more focused on the lower sales and margin contraction in the Medical Surgical Solutions segment, overshadowing growth in other areas of the company.

02.03.2025 - MCK Stock was up 2.9%

• Insights from options trading predict a bearish outlook for MCK, contrasting the notable bullish movement seen in the stock. This discrepancy may indicate a difference in sentiment between institutional investors and the market as a whole.
• Despite favorable recommendations from financial experts to purchase MCK shares, the stock surged significantly. Potential factors contributing to this surge include positive earnings, new business agreements, or other favorable company-specific developments.
• MCK's stock price saw a +0.74% increase compared to the previous trading day, which could be influenced by broader market trends, sector performance, or macroeconomic conditions affecting the healthcare industry.
• It is advisable for investors to keep a close watch on MCK's options market and company-specific updates to accurately assess future market movements.